VBContract PerformanceClaims through 2026-09-30 · CY2026
Portfolio
MSSP

MSSP Enhanced Track

Meeting financial and quality targets

On track
Attributed lives
14,200
Spend vs benchmark
-3.2%
$978 vs $1010 PMPM
Quality score
79
Gate 70
Projected settlement
$4.1M
Downside exposure $68.8M

Contract terms

Payer
CMS
Arrangement
Enhanced (75% / 40% loss)
Risk
Two-sided
Period
CY2026
Benchmark
$1010 PMPM
Shared savings
75%
Shared loss
40%
MSR
2%
Quality gate
70

Data completeness

90%

Claims through 2026-09-30. Recent months completed with IBNR estimates.

PMPM spend vs benchmark

Dashed = IBNR-estimated months

Quality measures

Marker = target
Controlling High BP
68% / 70%
37 gaps
Diabetes HbA1c <9
74% / 75%
13 gaps
Breast Cancer Screening
73% / 74%
10 gaps
Colorectal Screening
66% / 68%
31 gaps
Med Adherence – Statins
88% / 88%
Met

Utilization

Admits / 1000
228
ED / 1000
588
Readmit %
14.6
SNF days / 1000
990